Go Back   HER2 Support Group Forums > Articles of Interest
Register Gallery FAQ Members List Calendar Search Today's Posts Mark Forums Read

Thread Tools Display Modes
Old 06-05-2003, 03:28 AM   #1
Posts: n/a
The HERceptin® Adjuvant (HERA) Trial is a large-scale international clinical trial designed to determine if earlier use of the breast cancer drug Herceptin® (trastuzumab) can increase the length of survival without cancer recurrence in women whose early breast cancer has been diagnosed as HER2 positive. The Breast International Group (BIG) and F. Hoffmann-La Roche (Roche) are collaborating to conduct the HERA Trial.

To be eligible to participate in the trial patients must: (i)be diagnosed with primary breast cancer (ii) have been diagnosed as strongly HER2-positive (iii)have completed a course of standard systematic chemotherapy (standard chemotherapy administered before or after surgery) prior to enrolment.

It appears that the HERA trial is being conducted entirely outside the U.S.
  Reply With Quote

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is On

Forum Jump

All times are GMT -7. The time now is 03:43 PM.

Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2020, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007
free webpage hit counter